BPC-157 / TB-500 Blend (5mg / 5mg)

Research overview

The dual‑peptide combination of BPC‑157 and TB‑500—commonly known as the “Wolverine Stack”—is widely recognized as a synergistic approach in tissue repair and regeneration research. Their complementary mechanisms of action have demonstrated the potential to systemically promote tissue healing in preclinical models. BPC‑157 is a synthetic 15‑amino‑acid polypeptide derived from a fragment of human gastric juice protein. Preclinical studies have shown that it influences angiogenesis, inflammatory modulation, and tissue repair, with reported activities including wound healing acceleration, gastrointestinal mucosal protection, and neuroprotection in animal models. TB‑500 is the N‑terminally acetylated active fragment (amino acids 17–23) of the 43‑amino‑acid protein thymosin β4. Its primary mechanism centers on tissue regeneration: it promotes cell migration, angiogenesis, and inflammation reduction via its actin‑binding domain, which regulates cytoskeletal reorganization and provides a cellular basis for repair. When combined, BPC‑157 primarily supports angiogenesis and tissue protection, while TB‑500 enhances cell migration and tissue remodeling. Together, they establish a multi‑level repair network spanning vascular, cellular, and tissue dimensions, which has drawn particular interest in research on tendon, ligament, muscle, and connective tissue injuries. It should be noted, however, that current evidence is predominantly derived from animal models and in vitro experiments, and high‑quality human clinical trial data remain lacking.